跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 涵栩
教授
醫學系內科學科
電子郵件
chenhs
vghtpe.gov
tw
h-index
h10-index
h5-index
1939
引文
19
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
390
引文
11
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
219
引文
9
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1998 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(86)
類似的個人檔案
(6)
指紋
查看啟用 Harn-Shen Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Type 2 Diabetic Patients
94%
Taiwan
51%
Glycemic Control
48%
Hemoglobin A1c (HbA1c)
40%
Confidence Interval
35%
Insulin
31%
Growth Hormone
30%
Health-related Quality of Life
30%
Growth Factors
30%
Hazard Ratio
29%
Insulin-like
29%
Urinary Iodine Concentration
29%
Metabolic Syndrome
27%
Retinopathy
26%
Oral Glucose Tolerance Test
25%
Blood Glucose
25%
Ankle-brachial Index
24%
Iodine nutrition
24%
Renal Outcome
22%
Diabetic Patients
22%
All-cause Mortality
22%
Insulin Sensitivity
20%
Diabetic Kidney Disease
19%
Long-term Glycaemic Control
19%
Cell Function
18%
Fructosamine
18%
Plasma Glucose
18%
Basal Insulin Therapy
18%
Severe Hyperglycemia
17%
Diabetes
17%
Breast Milk
16%
Northern Taiwan
16%
Inductively Coupled Plasma Mass Spectrometry
16%
Composite Events
15%
Self-monitoring of Blood Glucose
15%
Diabetic
15%
Hyperglycemia
14%
HbA1c Levels
14%
Newly Diagnosed
14%
Iodine Concentration
14%
Randomized Controlled Trial
14%
Estimated Glomerular Filtration Rate
14%
Taipei
13%
Lactating Women
13%
Cardiovascular Prognosis
13%
Insulin Deficiency
13%
Glucose Homeostasis
13%
Albuminuria
13%
Heat Shock Protein 60 (HSP60)
13%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
73%
Diabetes Mellitus
40%
Hyperglycemia
40%
Hemoglobin A1c
36%
Cardiovascular System
36%
Patient with Type 2 Diabetes
34%
Glycemic Control
32%
Hazard Ratio
29%
Acromegaly
24%
Ankle Brachial Index
24%
Diabetic Nephropathy
23%
Diabetes
21%
Glomerular Filtration Rate
20%
Oral Glucose Tolerance Test
20%
All Cause Mortality
19%
Growth Hormone
18%
Insulin Sensitivity
18%
Insulin Treatment
18%
Cell Function
18%
Retinopathy
17%
Albuminuria
14%
Blood Pressure
14%
Urinary System
14%
Cardiovascular Risk
13%
Cardiovascular Disease
12%
Prevalence
12%
Metabolic Syndrome
12%
Tumor Necrosis Factor Receptor 1
12%
Quality of Life
12%
Octreotide
12%
Microalbuminuria
12%
Nutritional Status
12%
Human Milk
12%
Papillary Thyroid Cancer
12%
Creatinine
11%
Neoplasm
11%
Systolic Blood Pressure
11%
Blood Glucose
10%
Glycated Hemoglobin
10%
Cross Sectional Study
9%
Sitagliptin
9%
Glycon
9%
Obesity
9%
Impaired Fasting Glucose
8%
Somatomedin C
8%
Next Generation Sequencing
8%
Biological Marker
8%
Middle Age
8%
Nephropathy
8%
Thyroid Gland
8%
